Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia

Jarmo Hietala, Erkka Syvälahti, Harry Vilkman, +9

Schizophrenia Research

PsychiatryPsychotic DisorderDepressionSchizophreniaSocial Sciences +7

Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects

Aki Laakso, Harry Vilkman, Jörgen Bergman, +5

Biological Psychiatry

Healthy SubjectsPsychiatrySex DifferencesPsychopharmacologyNeuroscience +5

High Levels of Dopamine Activity in the Basal Ganglia of Cigarette Smokers

Raimo K. R. Salokangas, Harry Vilkman, Tuula Ilonen, +6

American Journal of Psychiatry

Striatal Dopamine Transporter Binding in Neuroleptic-Naive Patients With Schizophrenia Studied With Positron Emission Tomography

Aki Laakso, Harry Vilkman, Birgitta Alakare, +7

American Journal of Psychiatry

Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease

Valtteri Kaasinen, Kjell Någren, Jarmo Hietala, +5

Neurology

Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

Aki Laakso, Jörgen Bergman, Merja Haaparanta‐Solin, +4

Schizophrenia Research

PsychiatryNeurophysiologyPsychotic DisorderNeurotransmitterPsychopharmacology +8

Cortical glutamate–dopamine interaction and ketamine-induced psychotic symptoms in man

Sargo Aalto, Jouni Ihalainen, Jussi Hirvonen, +8

Psychopharmacology

NeuropsychologyPsychiatryPsychotic DisorderPsychopharmacologySchizophrenia +8

Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography

Jari Tiihonen, Harry Vilkman, Pirkko Räsänen, +10

Molecular Psychiatry

Positron Emission TomographyType 1Psychoactive DrugAlcohol DependenceAddiction +7

The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients

Christian C. Joyal, Mikko P. Laakso, Jari Tiihonen, +7

Biological Psychiatry

Neuroimaging BiomarkersNeuropsychologyNeuroimaging ModalityPsychiatryPsychotic Disorder +12

Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride

Jussi Hirvonen, Sargo Aalto, Ville Lumme, +6

Nuclear Medicine Communications